Recurrent parotid cavernous haemangioma in an adolescent, successfully treated with Propranolol.
Eur Ann Otorhinolaryngol Head Neck Dis
; 135(5S): S117-S119, 2018 Sep.
Article
en En
| MEDLINE
| ID: mdl-30139696
INTRODUCTION: Parotid haemangiomas account for the majority of salivary gland tumours in children. This articles highlights the use of medical treatment for the treatment of parotid haemangioma. CASE SUMMARY: A 4 year old male underwent a superficial parotidectomy for a parotid mass that was found to be a a parotid haemangioma on histology. At the age of 14 years he presented again with a parotid mass. He had imaging which aided the diagnosis of a parotid haemangioma being made. He was treated with successfully propranolol over a period of 6 months. DISCUSSION: There are no clear guidelines for treatment of parotid haemangiomas. These lesions can represent a clinical challenge and optimal management is controversial. It was proposed that propranolol be used for treatment in this particular case. This is a non-invasive form of treatment with minimal side effects.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Propranolol
/
Vasodilatadores
/
Neoplasias de la Parótida
/
Hemangioma Cavernoso
Tipo de estudio:
Guideline
/
Qualitative_research
Límite:
Adolescent
/
Humans
/
Male
Idioma:
En
Revista:
Eur Ann Otorhinolaryngol Head Neck Dis
Año:
2018
Tipo del documento:
Article
Pais de publicación:
Francia